Does the CMA have any recommendation on a body that would be charged with the responsible development of a formulary? We've had CADTH present here. They're doing a ton of work across Canada. Is that what you view as the most likely place to park responsibility for that evidence-based approach to developing a formulary?
On June 1st, 2016. See this statement in context.